本页面由Tiger Trade Technology Pte. Ltd.提供服务

Adaptive Biotechnologies Corp

14.52
-0.4300-2.88%
盘后14.520.00000.00%16:10 EDT
成交量:183.92万
成交额:2,694.04万
市值:22.33亿
市盈率:-37.03
高:15.05
开:14.95
低:14.11
收:14.95
52周最高:20.76
52周最低:6.26
股本:1.54亿
流通股本:1.17亿
量比:0.88
换手率:1.57%
股息:- -
股息率:- -
每股收益(TTM):-0.3922
每股收益(LYR):-0.3922
净资产收益率:-27.82%
总资产收益率:-6.79%
市净率:10.21
市盈率(LYR):-37.03

数据加载中...

2026/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/28

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/02/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/26

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/06

重要事件披露

Form 8-K - Current report
2026/02/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/12

重要事件披露

Form 8-K - Current report
2026/01/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/30

重要事件披露

Form 8-K - Current report
2025/12/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities